台達化1309.TW Overview
1309
台達化
-1.73%
(-0.02)
1309 Overall Performance
1309 AI Analysis & Strategy
Browsing restrictions can be lifted for a fee.
1309 Current Performance
-1.70%
台達化
-0.44%
Avg of Sector
-0.01%
TAIEX
1309 Key Information
1309 Profile
Taita Chemical Company, Limited produces and sells styrenics in Taiwan, Mainland China, Hong Kong, and the United States. It offers acrylonitrile-butadiene-styrene resin, a terpolymer plastic under the TAITALAC brand; general purpose and high impact polystyrene under the TAITAREX brand name for use in food containers, CD cases, stationary, toys, insulation boards, business machines, electric and electrical appliances, and consumer goods; and expandable polystyrene resins under the TAITACELL brand name. The company also provides glass wool materials; and engages in cubic printing, a process for applying decorative pattern to 3-dimensional products in various applications, including auto parts, home electronic appliances, IT products, home decoration, sport goods, stationery and gifts, and others. In addition, it engages in export activities. Taita Chemical Company, Limited was incorporated in 1960 and is headquartered in Taipei, Taiwan.
1309 FAQ
When is 1309's latest earnings report released?
The most recent financial report for 台達化 (1309) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 1309's short-term business performance and financial health. For the latest updates on 1309's earnings releases, visit this page regularly.
What is the operating profit of 1309?
According to the latest financial report, 台達化 (1309) reported an Operating Profit of -104.6M with an Operating Margin of -2.72% this period, representing a decline of 7.68% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is 1309's revenue growth?
In the latest financial report, 台達化 (1309) announced revenue of 3.85B, with a Year-Over-Year growth rate of -22.12%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much cash does 1309 have?
At the end of the period, 台達化 (1309) held Total Cash and Cash Equivalents of 787.73M, accounting for 0.09 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does 1309 go with three margins increasing?
In the latest report, 台達化 (1309) did not achieve the “three margins increasing” benchmark, with a gross margin of 4.1%%, operating margin of -2.72%%, and net margin of -6.32%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 1309's profit trajectory and future growth potential.
Is 1309's EPS continuing to grow?
According to the past four quarterly reports, 台達化 (1309)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.61. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of 1309?
台達化 (1309)'s Free Cash Flow (FCF) for the period is 41.75M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 65.84% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.